Truist raised the firm’s price target on Argenx (ARGX) to $950 from $918 and keeps a Buy rating on the shares. The firm is updating its model after the company’s Q3 results to reflect the strong Vyvgart beat and upbeat commentary on the forward outlook, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX: